๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial

โœ Scribed by Camiel Verhamme; Rob J de Haan; Marinus Vermeulen; Frank Baas; Marianne de Visser; Ivo N van Schaik

Book ID
115022035
Publisher
BioMed Central
Year
2009
Tongue
English
Weight
478 KB
Volume
7
Category
Article
ISSN
1741-7015

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II, multicenter, randomized, dou
A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)
โœ E. Anaissie; M.W. Schuster; D. Hurd; W. Bensinger; J. Mason; J.M. McCarty; R. Ri ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 64 KB